Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
Apply
TGFBR2 KO CAR27/IL-15 NK Cells
Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step